Saturday, April 06, 2024 2:29:09 PM
Networks: People connected by relationships, which can take on a variety of forms, both formal and informal.
Dr. Sonny Bal MD, JD, MBA, PHD current Chairman, CEO, CFO
Designer Surgeon Panel, Zimmer Inc., Warsaw, Indiana, 2002 to present.
We now have evidence that Sintx was testing its femoral head along with a Biomet liner when Dr. Bal joined Sintx as a surgeon designer while also being a surgeon designer for Zimmer. Dr. Bal was brought on to assist Sintx with designing hip/knee implants which would have included Biomets liner. Dr Bal continued his position as a surgeon designer for Zimmer up to at least 2014 while he was on the board of Sintx (2012).
Dr. Bal and former Zimmer Biomet CEO, David Dvorak (2007-2017) join OREF board of trustees together.
In addition, the trustees welcome to the board:
B. Sonny Bal, MD, JD, MBA (Columbia, MO); Paul C. Collins, MD (Boise, ID); David C. Dvorak, JD (Warsaw, IN)
Dr. Link, PHD
Max Link, Ph.D. has served as the Chairman of our board of directors since October 2003. Dr. Link served as Chairman of the Board and Chief Executive Officer of Centerpulse AG, the largest orthopedics company in Europe, from March 2002 until October 2003, when Centerpulse was acquired by Zimmer Holdings, Inc.
Dr Link, former CEO of Centerpulse until acquired by Zimmer in 2003 was Sintx Chairman until 2014 when he stepped down for health reasons. Passing away shortly after.
Dr. Aaron Hofmann, MD Co-Founder of Sintx.
Aaron A. Hofmann, M.D. is our co-founder and has been a member of our board of directors since 1996.
Since 2003, Dr. Hofmann has been a design surgeon for Zimmer Holdings, Inc.
Dr Hofmann began as a surgeon designer for Centerpulse before Zimmer acquired it in 2003. Thus Dr. Hofmann has been tied to Centerpulse/Zimmer since Sintx founding.
Dr. G. Pezzotti, PHD
I do not have official evidence of research collaboration between Biomet and Dr Pezzotti. What i do have is a list of about 8 research papers that Dr Pezzotti did on behalf of Biomet suggesting that Biomet used Pezzotti as a scientific advisor like the function he provides for Sintx.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660
Dr Saurabh Lal, PHD (Si3N4 coatings expert)
Dr. Lal has never been directly connected to Sintx that im aware of. Hes included in this list because of his extensive Si3N4 work for European Unions Life Long Joints program for which Sintx has been a partner in. He serves as a Principle Engineer at Zimmer Biomet in Swindon, UK as part of its anti-infection coatings program. He was hired December 2018.
Consulting Surgeons
Dr. Mark P Arts, MD & Dr. Jasper Wolf, MD
The authors MA and JW receive research grants from Zimmer-Biomet, EIT and Intrinsics. MA and JW are consultants for Zimmer-Biomet and Silony and they receive royalties from EIT.
Dr. Paul Saiz, MD
Dr. Saiz has worked as a Consultant for Zimmer Spine
Dr. Paul Suh, MD
Dr. Suh or an immediate family member has received royalties from Zimmer Biomet, is a member of a speakers’ bureau or has made paid presentations on behalf of Eli Lilly, and serves as a paid consultant to or is an employee of Amedica and Zimmer Biomet.
Dr. Hieu Ball, MD
2015 Consulting revenue from LDR & Zimmer Biomet – $92,500
2014 Consulting revenue from LDR, Biomet, & Amedica – $107,000
Others worth mentioning that had brief stinks at Sintx when it was Amedica:
Jamey Rottman: VP of Medical education and training for Zimmer Biomet before joined Sintx 2017
Dana Lyons: Sales Vice President with Zimmer Spine before joining Sintx in 2016
Ryan Long: Sales VP Southwest before before joining Sintx as regional VP of Sales
There are more than this in Sintx 2007 IPO paperwork. Several former Centerpulse employees worked at Sintx for a time when Sintx first tried to IPO.
Quote Sources:
Sintx - Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353
https://web.archive.org/web/20240326041531/https://www.prweb.com/releases/orthopaedic_research_and_education_foundation_welcomes_new_board_and_committee_members/prweb13440909.htm
https://amedicablog.wordpress.com/2017/09/12/zimmer-amedica-connections-via-personnel/
https://www.researchgate.net/profile/Saurabh-Lal
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:05:43 PM
- SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies • GlobeNewswire Inc. • 11/13/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:17:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2025 01:00:06 PM
- SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System • GlobeNewswire Inc. • 11/03/2025 01:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/23/2025 08:31:09 PM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
